Chemotherapy Dosage Limitations

Introduction to Chemotherapy Dosage Limitations

The dosage of non-targeted, traditional chemotherapeutic drugs is limited by the impact on normal bone marrow cells, not neoplastic cells, resulting in myelosuppression 1

Chemotherapy dosing protocols are designed to allow for bone marrow recovery between cycles, as recommended by the American Society of Clinical Oncology, with a strength of evidence level of high 1
Regular monitoring of blood counts is essential during chemotherapy to assess myelosuppression, according to the National Comprehensive Cancer Network, with a strength of evidence level of high 2
Management of myelosuppression requires antibiotic therapy, transfusion support, and potentially growth factors, as suggested by the European Society for Medical Oncology, with a strength of evidence level of moderate 1